쿠라 온콜로지, Inc.
DE ˙ DB ˙ US50127T1097
€7.56 ↑0.24 (3.28%)
2026-06-05
주가
SecurityDE:KUR / Kura Oncology, Inc.
InstitutionAlliancebernstein L.p.
Latest Disclosed Ownership84,800 shares
Latest Disclosed Value $ 881,072
Alliancebernstein L.p. ownership in KUR / Kura Oncology, Inc.

On May 15, 2026 - Alliancebernstein L.p. filed a 13F-HR form disclosing ownership of 84,800 shares of Kura Oncology, Inc. (DE:KUR) valued at $563,920 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 84,800 shares of Kura Oncology, Inc.. This represents a change in shares of 0.00% during the quarter. The current value of the position is $641,088 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F KURA ONCOLOGY COM 50127T109 84,800 0 0.00 881 0.00 0.0002
2026-02-17 2025-12-31 13F KURA ONCOLOGY COM 50127T109 84,800 0 0.00 881 17.47 0.0003
2025-11-14 2025-09-30 13F KURA ONCOLOGY COM 50127T109 84,800 0 0.00 750 53.37 0.0002
2025-08-14 2025-06-30 13F KURA ONCOLOGY COM 50127T109 84,800 0 0.00 489 -12.52 0.0002
2025-05-15 2025-03-31 13F KURA ONCOLOGY COM 50127T109 84,800 0 0.00 560 -24.25 0.0002
2025-02-12 2024-12-31 13F KURA ONCOLOGY COM 50127T109 84,800 0 0.00 739 -55.43 0.0003
2024-11-14 2024-09-30 13F KURA ONCOLOGY COM 50127T109 84,800 0 0.00 1,657 -5.15 0.0006
2024-08-14 2024-06-30 13F KURA ONCOLOGY COM 50127T109 84,800 0 0.00 1,746 -3.43 0.0006
2024-05-14 2024-03-31 13F KURA ONCOLOGY COM 50127T109 84,800 4,700 5.87 1,809 57.08 0.0006
2024-02-14 2023-12-31 13F KURA ONCOLOGY COM 50127T109 80,100 0 0.00 1,152 57.67 0.0004
2023-11-14 2023-09-30 13F KURA ONCOLOGY COM 50127T109 80,100 -125,000 -60.95 731 -66.34 0.0003
2023-08-15 2023-06-30 13F KURA ONCOLOGY COM 50127T109 205,100 125,000 156.05 2,170 121.55 0.0009
2023-05-15 2023-03-31 13F KURA ONCOLOGY COM 50127T109 80,100 0 0.00 980 -1.51 0.0004
2023-02-15 2022-12-31 13F KURA ONCOLOGY COM 50127T109 80,100 -167,245 -67.62 994 -70.58 0.0004
2022-11-15 2022-09-30 13F KURA ONCOLOGY COM 50127T109 247,345 95,712 63.12 3,379 21.59 0.0016
2022-08-15 2022-06-30 13F KURA ONCOLOGY COM 50127T109 151,633 -66,118 -30.36 2,779 -20.62 0.0013
2022-05-13 2022-03-31 13F KURA ONCOLOGY COM 50127T109 217,751 137,851 172.53 3,501 212.87 0.0014
2022-02-14 2021-12-31 13F KURA ONCOLOGY COM 50127T109 79,900 0 0.00 1,119 -25.25 0.0004
2021-11-10 2021-09-30 13F KURA ONCOLOGY COM 50127T109 79,900 0 0.00 1,497 -10.14 0.0006
2021-07-30 2021-06-30 13F KURA ONCOLOGY COM 50127T109 79,900 -40,018 -33.37 1,666 -50.86 0.0007
2021-05-06 2021-03-31 13F KURA ONCOLOGY COM 50127T109 119,918 41,218 52.37 3,390 31.91 0.0015
2021-02-08 2020-12-31 13F KURA ONCOLOGY COM 50127T109 78,700 13,000 19.79 2,570 27.67 0.0012
2020-11-12 2020-09-30 13F KURA ONCOLOGY COM 50127T109 65,700 -1,900 -2.81 2,013 82.67 0.0011
2020-08-13 2020-06-30 13F KURA ONCOLOGY COM 50127T109 67,600 29,900 79.31 1,102 193.87 0.0006
2020-05-14 2020-03-31 13F KURA ONCOLOGY COM 50127T109 37,700 10,100 36.59 375 -1.32 0.0003
2020-02-18 2019-12-31 13F KURA ONCOLOGY COM 50127T109 27,600 0 0.00 380 -9.31 0.0002
2019-11-14 2019-09-30 13F KURA ONCOLOGY COM 50127T109 27,600 0 0.00 419 -22.84 0.0003
2019-08-14 2019-06-30 13F KURA ONCOLOGY COM 50127T109 27,600 1,900 7.39 543 27.46 0.0003
2019-05-14 2019-03-31 13F KURA ONCOLOGY COM 50127T109 25,700 -900 -3.38 426 14.21 0.0003
2019-02-13 2018-12-31 13F KURA ONCOLOGY COM 50127T109 26,600 3,900 17.18 373 -6.05 0.0003
2018-11-08 2018-09-30 13F KURA ONCOLOGY COM 50127T109 22,700 5,900 35.12 397 29.74 0.0003
2018-08-13 2018-06-30 13F KURA ONCOLOGY COM 50127T109 16,800 5,400 47.37 306 42.99 0.0002
2018-05-14 2018-03-31 13F KURA ONCOLOGY COM 50127T109 11,400 11,400 214 0.0002
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.